Medetomidine Impurity 34

Medetomidine Impurity 34 Struktur
86347-44-6
CAS-Nr.
86347-44-6
Englisch Name:
Medetomidine Impurity 34
Synonyma:
Medetomidine Impurity 34;Dexmedetomidine Impurity 68;Dexmedetomidine Impurity 17 HCl;4-(1-(2,5-dimethylphenyl)ethyl)-1H-imidazole;1H-Imidazole, 5-[1-(2,5-dimethylphenyl)ethyl]-;4-(1-(2,5-dimethylphenyl)ethyl)-1H-imidazole hydrochloride
CBNumber:
CB54813061
Summenformel:
C13H16N2
Molgewicht:
200.28
MOL-Datei:
86347-44-6.mol

Medetomidine Impurity 34 Eigenschaften

Siedepunkt:
375.8±11.0 °C(Predicted)
Dichte
1.053±0.06 g/cm3(Predicted)
pka
14.29±0.10(Predicted)

Sicherheit

Medetomidine Impurity 34 Chemische Eigenschaften,Einsatz,Produktion Methoden

Medetomidine Impurity 34 Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


Medetomidine Impurity 34 Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 8)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Shijiazhuang yaoBo Pharmaceutical Co., Ltd. 15633056635
2880679888@qq.com China 2826 58
Shenzhen SUNGENING Bio-Medical Co., Ltd. 0755-28967200 13631290199
wxf@sungening.com China 9592 60
Jinan blalong chemical co. LTD 2710913286@.com
1513643261@qq.com China 14253 58
Shandong Wadesen Biotechnology Co. LTD 0531-88723173 18596073690
1047208234@qq.com China 3901 58
SHENZHEN PHYSTANDARD BIO-TECH CO.,LTD 0755-0755-0755-83725350 13380397412
3001280422@qq.com China 10077 58
Changzhou Xianglong Pharmaceutical Technology Co., LTD 18661161657
yaoxiangqiu2021@163.com China 9998 58
Cato Research Chemicals Inc. 020-81960175-877 18933936954
tianwen.zhan@cato-chem.com China 7737 58
Shanghai YuZn Pharm. Technology Co.,Ltd. 15921286451; 15921286451
2010681527@qq.com China 5069 58

  • Medetomidine Impurity 34
  • Dexmedetomidine Impurity 17 HCl
  • 4-(1-(2,5-dimethylphenyl)ethyl)-1H-imidazole hydrochloride
  • 4-(1-(2,5-dimethylphenyl)ethyl)-1H-imidazole
  • 1H-Imidazole, 5-[1-(2,5-dimethylphenyl)ethyl]-
  • Dexmedetomidine Impurity 68
  • 86347-44-6
Copyright 2019 © ChemicalBook. All rights reserved